PL
PL · PL · PL-100470351
Rinvoq
ATC L04AF03
Last synced from URPL (Poland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeL04AF03
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin08054083022994
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "30 mg",
"packaging": "Rpz ¦ EU/1/19/1404/009 ¦ 145472\n98 tabl.\nRpz ¦ EU/1/19/1404/007 ¦ 145473\n30 tabl.\nRpz ¦ EU/1/19/1404/008 ¦ 145474\n90 tabl.\n08054083022994 ¦ Rpz ¦ EU/1/19/1404/006 ¦ 145475\n28 tabl.",
"substance": "Upadacitinibum 30 mg",
"common_name": "Upadacitinibum",
"pl_product_id": "100470351",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L04AF03.
Access this data programmatically
Query Rinvoq and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.